# Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics

> **NCT04091711** · NA · SUSPENDED · sponsor: **Dosentrx Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Oncology
- Adherence, Medication
- Side Effect

## Interventions

- **DEVICE:** ReX-C system

## Key facts

- **NCT ID:** NCT04091711
- **Lead sponsor:** Dosentrx Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-04-21
- **Primary completion:** 2022-12
- **Final completion:** 2023-02
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Awaiting next model of the device
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04091711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04091711, "Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04091711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*